Valérie Chapoulaud-Floquet spent over 25 years in the luxury products and consumer goods industries, during which she held senior executive positions at L'Oréal's Luxury Products Division and Louis Vuitton. She is the former Global CEO of Rémy Cointreau and now sits on the boards of numerous companies, including Diageo, Sofisport, NextStage, and Jacobs Holding.
In 2019, Wolfson enjoyed an exhibition of the stunning design innovations of Joseph Joseph, the company Richard and his brother Antony founded in 2003. Specialising in contemporary housewares, Joseph Joseph is now internationally recognised for producing some of the most stylish and technically innovative products available, and has become one of the fastest growing companies in this market worldwide. Joseph Joseph sells over 400 products to more than 100 countries, with offices in London, New York, Paris, Düsseldorf, Shanghai, and Tokyo. Richard studied Industrial Design at Loughborough University followed by Advanced Design and Manufacturing at Cambridge University, and is Chief Executive.
Dr. Jason Mellad
Jason Mellad is a scientist and entrepreneur who co-founded and serves as CEO for Start Codon, a healthcare startup accelerator. Previously, Jason was CEO of Cambridge Epigenetix, which developed a proprietary epigenetic biomarker discovery platform. While at Cambridge Epigenetix, he transformed the research tools company into a leading liquid biopsy player and led two successful investment rounds totaling $49.8M. Jason was awarded a Marshall Scholarship to obtain his PhD in Medicine from University of Cambridge.
Dr. Ronjon Nag
Ronjon Nag has invented and deployed artificial intelligence systems for over three decades. He received a PhD in engineering from Cambridge (Wolfson '84), an MS from MIT, and the IET Mountbatten Medal at the Royal Institution. Companies he has co-founded have been sold to Motorola and Blackberry. He advised VocalIQ, started by a Wolfson College founder, sold to Apple. He is currently an Interdisciplinary Distinguished Careers Institute Fellow at Stanford University and President of R42 Institute, a think tank and deep science venture firm.
Michael O'Sullivan has extensive executive and international experience, having held the Chief Executive positions of the EU Chamber of Commerce in China, the Cambridge Commonwealth, European, and Overseas Trust, as well as Cambridge Assessment International Education. He received his MPhil from Cambridge ('85) and BA from Oxford ('82), and was made Companion of the Order of St. Michael and St. George ('08). He is now an international education consultant and Wolfson College Fellow.
Dr. Tony Raven
Tony has a long history as a successful technology entrepreneur. The companies he has founded include Summit Technology, the pioneer of laser refractive surgery, which was acquired by Nestle Alcon in 2000 for $893 million; publicly-quoted Cambridge technology consultance Sagentia plc; and Diomed Inc, a pioneer of surgical diode lasers which was listed in the US in 2002 before being acquired by Angiodynamics Inc in 2008. Tony is a Fellow of the Institute of Physics and a Member of the Institute of Directors. He joined Cambridge Enterprise as CEO in December 2011.
Dr. Robert Sansom
Robert Sansom is an active angel investor and mentor to high-technology start-up businesses in the UK and US. He is the Founder of Cambridge Angels, a group of seasoned technology and bio-technology entrepreneurs who invest in and mentor technology start-ups in the Cambridge area. Prior to being an angel investor, he was co-founder and Chief Technology Officer of FORE Systems, a leading developer of high-speed data communications systems which was sold to sold to Marconi in 1999. Robert is a board member of a number of businesses including Arachnys, CCS, Featurespace, IQGeo, Myrtle Software, and Netronome Systems.
Alex van Someren
Alex is Managing Partner of the Early Stage Funds at Amadeus Capital, and he sits of the boards of several Amadeus portfolio companies. Alex has a current investment focus on UK deep technology and is a co-founder of Cyber London, Europe's first cybersecurity accelerator programme. Alex co-founded ANT Ltd in 1990 to produce networking products, including web browser software licensed to the Oracle Corporation. ANT plc was listed on the London AIM market in 2005 and later acquired by Espial. In 1996 he co-founded nCipher with venture capital backing to develop internet security products using advanced cryptography, before leading the company to an IPO on the London Stock Exchange in 2000 at a £350 million valuation. nCipher plc was sold to Thales SA in 2008. Alex lives in Cambridge, UK and is married with three children.
Dr. Blaise Thomson
Blaise is the founder/CEO of Bitfount, a federated machine learning startup, and director of Alfa iQ, the joint venture between Alfa Systems and Bitfount bringing machine learning to asset finance. Prior to Bitfount and Alfa iQ, Blaise was the founder/CEO of VocalIQ, which he sold to Apple in 2015. He stayed at Apple until 2019 as head of the Cambridge, UK engineering team and Chief Architect for Siri Understanding. He is an Honorary Fellow at Cambrige University's Judge Business School.